Pfizer Inc (NYSE:PFE) price on current trading day, fall -0.48% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $25.98.
A look at the stock’s price movement, the level at last check in today’s session was $26.10. The PE ratio in trailing twelve months stood at 18.45. Turning to its 52-week performance, $31.54 and $24.48 were the 52-week high and 52-week low respectively. Overall, PFE moved -2.42% over the past month.
Pfizer Inc’s market cap currently stands at around $147.20 billion, with investors looking forward to this quarter’s earnings report slated for in March. The company has a Forward Dividend ratio of 1.69, with its dividend yield at 6.51%. As such, investors might be keen on an upside in the stock’s price ahead of the scheduled earnings report.
Analysts have a consensus estimate of 14.43B for the company’s revenue for the quarter, with a low and high estimate of 13.94B and 15.25B respectively. The average forecast suggests down to a -3.03% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 62.97B, representing a -1.03% decline on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PFE is a 50% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
16 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 7 analyst(s) rate the stock as a Hold, 7 recommend PFE as a Buy and 1 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 1 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
PFE’s current price about -0.13% and -1.22% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 47.25, while 7-day volatility ratio is 2.30% and 2.14% in the 30-day chart. Further, Pfizer Inc (PFE) has a beta value of 0.58, and an average true range (ATR) of 0.52. Analysts have given the company’s stock an average 52-week price target of $32, forecast between a low of $32 and high of $33. Looking at the price targets, the low is -23.17% off recent price level in today’s trading while to achieve the yearly target high, it has to move -27.02%. Nonetheless, investors will most likely welcome a -23.17% jump to $32 which is the analysts’ median price.
If we refocus on Pfizer Inc (NYSE:PFE), historical trading data shows that trading volumes averaged 39.74 million over the past 3 months. The company’s latest data on shares outstanding shows there are 5.67 billion shares.
The 0.07% of Pfizer Inc’s shares are in the hands of company insiders while institutional holders own 67.05% of the company’s shares. Current price change has pushed the stock -2.09% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PFE stock continues to rise going into the next quarter.
